Heartflow, Inc. (HTFL)
Heartflow will go public soon. The estimated IPO date is August 8, 2025.
IPO Price Range
$15.00 - $17.00
Shares Offered
12,500,000
Deal Size
$200.00M
Company Description
Heartflow hs pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide.
As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.
To date, we have developed three software products (with a fourth product expected to launch in 2026) under the Heartflow Platform that provide physicians with the critical insights needed to effectively diagnose and manage CAD.
Heartflow, Inc.
Country | United States |
Founded | 2007 |
IPO Date | Aug 8, 2025 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 699 |
CEO | John C.M. Farquhar |
Contact Details
Address: 331 E. Evelyn Avenue Mountain View, CA 94041 United States | |
Phone | (650) 241-1221 |
Website | heartflow.com |
Stock Details
Ticker Symbol | HTFL |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001464521 |
Employer ID | 26-0506743 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
John C.M. Farquhar | President, Chief Executive Officer and Director |
Vikram Verghese | Chief Financial Officer |
Campbell D.K. Rogers, M.D. | Chief Medical Officer |
William C. Weldon | Director and Chair of the Board of Directors |
Timothy C. Barabe | Director |
Julie A. Cullivan | Director |
Nicholas Downing, M.D. | Director |
Jeffrey C. Lightcap | Director |
Wayne J. Riley, M.D. | Director |
Lonnie M. Smith | Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 1, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Jul 17, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Jun 23, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
Apr 18, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
Mar 27, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
Feb 6, 2025 | DRS | [Cover] Draft Registration Statement |
Jun 14, 2019 | D | Notice of Exempt Offering of Securities |
Dec 4, 2017 | D | Notice of Exempt Offering of Securities |
May 20, 2016 | D/A | Filing |
Feb 12, 2015 | D | Notice of Exempt Offering of Securities |